Events
Email Page
Demonstrating Biosimilarity: Guidance from the FDA
June 5, 2014

Axinn Counsel Stacie Ropka presented, "Demonstrating Biosimilarity: Guidance from the FDA," at the American Conference Institute's fifth annual Summit on Biosimilars. 

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.